Norma Ann Provencio
CIK 1343811 · last filed 2025-11-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.17M
Companies
2
Total Filings
102
Lifetime Open-Market Net
$236.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BZH | Director | 115,988 | $27.37 | $3.17M | $158.4K | 17 | 2025-11-18 |
| VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Director | 2,500 | — | — | $77.6K | 39 | 2010-09-30 |
Recent Filings · Page 6 of 11
102 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-10-03 | — | Grant (A) | +757 | $0 | |
| 2011-08-11 | — | Buy (P) | +2,255 | $92.2K | |
| 2011-07-27 | — | Grant (A) | +354 | $0 | |
| 2011-05-23 | — | Grant (A) | +4,397 | $0 | |
| 2011-05-17 | — | Buy (P) | +2,000 | $101.1K | |
| 2011-04-11 | — | Grant (A) | +143,009 | $0 | |
| 2011-04-11 | — | Buy (P) | +5,000 | $123.8K | |
| 2011-04-11 | — | Buy (P) | +1,575 | $62.8K | |
| 2011-03-08 | — | Mixed | +1,575 | $62.8K | |
| 2010-11-15 | — | Grant (A) | +4,500 | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.